Anthera Pharmaceuticals plans to conduct public offering of stock

Bookrunners Citigroup Global Markets, Piper Jaffray assist with sale

By Devika Patel

Knoxville, Tenn., July 8 – Anthera Pharmaceuticals, Inc. said it will price a public sale of common stock with a 15%, 30-day greenshoe.

Citigroup Global Markets Inc. and Piper Jaffray & Co. are the bookrunners.

Proceeds will be used for clinical research, development and general corporate purposes.

Anthera, based in Hayward, Calif., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.